During the forecast period of 2023 to 2033, the global idiopathic pulmonary fibrosis management industry size is anticipated to grow at a CAGR of 1.5% from a market value of US$ 3145 million in 2023 to US$ 3649.90 million. The rising prevalence of the condition in men around the world is responsible for the expansion …